Firms Race to Develop Muscle-Preservation Therapies

Multiple companies are competing to develop treatments that preserve muscle mass, likely targeting age-related sarcopenia or disease-related cachexia. The article is exclusive and requires subscription, so details on specific candidates or trial results are unavailable. This signals growing commercial interest in a niche therapeutic area with potential market implications.